CJC-1295 / Ipamorelin Blend
Two lab-made peptides in one freeze-dried vial, in equal amounts: CJC-1295 (no DAC) and Ipamorelin.
Where it came from
Ipamorelin was developed at the drug company Novo Nordisk and described in 1998. CJC-1295 was developed by ConjuChem Biotechnologies in Montreal and first described in 2005. The version in this vial, without DAC, is the same 29-amino-acid chain without ConjuChem's add-on, also called Mod GRF 1-29.
Pairing the two in one vial is a recent practice among research suppliers. No single paper or person is behind the combination.
What's in the vial
- CJC-1295: CJC-1295 without DAC (also called Mod GRF 1-29) is a lab-made peptide of 29 amino acids, based on the first part of a natural hormone called GHRH, with four building blocks swapped for sturdier ones.
- Ipamorelin: Ipamorelin is a lab-made peptide of just five amino acids, developed at Novo Nordisk in the 1990s.
Each one has its own note with its full history.
At a glance
| Detail | Value |
|---|---|
| Contents | CJC-1295 (no DAC) 5mg, Ipamorelin 5mg |
| Form | One freeze-dried vial |
| Storage | Sealed in a freezer at -20 °C, away from light |
Lab reports
Every batch (called a lot) of CJC-1295 / Ipamorelin Blend is tested by an independent lab. The report shows the lab, the test date, the lot number, how pure the sample is and how much is in the vial, with each peptide listed separately. Find them on the Certificates of Analysis page. New to lab reports? Start with How to read a peptide lab report.
Storage
Keep the vial sealed in a freezer at -20 °C, away from light, and let it warm to room temperature before opening so moisture doesn't get in. More in Storing lyophilized (freeze-dried) peptides in the lab and the Research handling guidelines.
For research use only. Not for human or veterinary use.